China's pharmaceutical goods exports have exhibited a consistent growth pattern from 2024 to 2028, with values forecasted to rise steadily from 241.3 thousand metric tons in 2024 to 264.48 thousand metric tons in 2028. In 2023, the exports stood at 235 thousand metric tons, indicating an increase of 2.68% from 2023 to 2024. Year-on-year, the exports are anticipated to grow by approximately 2.43% in 2025, 2.36% in 2026, 2.28% in 2027, and 2.21% in 2028. Over the last five-year period, the compound annual growth rate (CAGR) is projected at around 2.39%.
Future trends to watch for in China's pharmaceutical exports include:
- The impact of regulatory changes and international trade policies.
- Advancements in biotechnology and their export potential.
- Shifts in global demand due to emerging markets and aging populations.
- Strategic partnerships and investments in research and development.
